Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Performant Finl 2024 guidance: Healthcare revenue: $117M-$122M; Adj. EBITDA: $4M-$5M.

Author: Benzinga Newsdesk | November 06, 2024 04:16pm

Performant Finl (NASDAQ:PFMT) .

Posted In: PFMT